Skip to main content
. 2018 May 24;73(9):2529–2539. doi: 10.1093/jac/dky184

Figure 2.

Figure 2.

Model inputs and outputs relating to (a) Clostridium difficile infection recurrence and relative risk of recurrence and (b) costs (base-case analysis). EPFX, extended-pulsed fidaxomicin; RR, relative risk. An asterisk indicates P <0.001 according to the Cochran–Mantel–Haenszel test adjusted for stratification factors.